Contact
Guarantors |
|
| Chief Guarantor | Ing. Zdena Sulová, DrSc. |
| Co-Guarantors | RNDr. Viera Boháčová, CSc |
| Mgr. Mário Šereš, PhD. | |
Supervisors CBs IMFG |
|
| doc. Ing. Albert Breier, DrSc. | |
| doc. RNDr. Ľubica Lacinová, DrSc. | |
| Mgr. Jana Gaburjaková, PhD. | |
| Mgr. Marta Gaburjaková, PhD. | |
| MMedSc. Eliyahu Dremencov, PhD. | |
| Mgr. Jana Královičová, PhD. | |
Supervisors CBs IABG |
|
| RNDr. Ivan Hapala, CSc. | |
| RNDr. Petr Griač, CSc. | |
| Mgr. Peter Valachovič, PhD. | |
External supervisors |
|
| RNDr. Katarína Bíliková, PhD., Institute of Forest Ecology SAS | |
| RNDr. Dušan Žitňan, DrSc., Institute of Zoology SAS | |
Dissertation topics in the graduate program Biochemistry – academic year 2017/2018:
| Site: | Department of Cell Physiology and Genetics (DCPG) Centre of Biosciences, SAS – Institute of Molecular Physiology and Genetics SAS, Dúbravská cesta 9, Bratislava |
| Topic: | Regulation of neuronal excitability through opioid receptors. |
| Study form: | internal Intended for Slovak students |
| Supervisor: | doc. RNDr. Ľubica Lacinová, DrSc. lubica.lacinova@savba.sk |
Annotation:
Neuronal excitability is regulated by numerous receptors. Student will examine regulation of neuronal excitability by ligands of opioid receptors in a primary culture of neuronal cells and/or in neuronal slices. Electrophysiological methods (e.g., patch clamp) will be applied for this investigation and may be supplemented by methods of molecular biology for studying alteration in expression of signaling proteins. Student must be able to study in English.
| Site: | Department of Cell Physiology and Genetics (DCPG) Centre of Biosciences, SAS – Institute of Molecular Physiology and Genetics SAS, Dúbravská cesta 9, Bratislava |
| Topic: | Early preclinical assessment of the effectiveness of novel antidepressant drugs. |
| Study form: | internal Training in English |
| Supervisor: | Eliyahu Dremencov, MMedSc, PhD eliyahu.dremencov@savba.sk |
Annotation:
The aim of the project will be to assess the effectiveness of the novel potential antidepressant drugs, such as ligands of trace amine-associated one (TAAR1), delta opioid (DOR), oxytocin (OR), and vasopressin receptors. These ligands will be administered to the laboratory rats and their effects on the excitability of brain serotonin, norepinephrine, and dopamine neurons will be examined. This project will be performed in a collaboration with the industrial biopharmaceutical sector.